GET THE APP

..

Journal of Blood & Lymph

ISSN: 2165-7831

Open Access

Articles in press and Articles in process

    Editorial Pages: 1 - 1

    Pharmacokinetic Properties of Anticancer Medications in Chemotherapy

    Melisyah Meliana

    Pharmacokinetics is the investigation of digestion of medications in organic liquids, tissues and excreta. The discoveries of ongoing improvements uncover that Multidrug Obstruction (MDR) adjusted the bioavailability of orally managed drugs through enlistment or restraint. Part of Multi-drug treatment: MDR is a term used to portray the marvel described by the capacity of medication safe tumors to display synchronous protection from various primarily and practically disconnected chemotherapeutic specialists. Various systems have been portrayed to clarify the wonder of MDR in mammalian cells. They have been extensively ordered into cell and non-cell components. Boundaries of pharmacokinetic inconstancy in malignancy patients:

    Commentary Pages: 1 - 1

    Compensatory Rehabilitation in the Complete 10,11,12 Thoracic level injury

    Jeena Aniston

    Share this article

    Road traffic accidents are increasing day by day which will result in Spinal cord Injury to the victims. In Spinal cord Injury nervous system is affected which is not re-gene ratable so whatever damage occur its permanent for rest of life. Thoracic spinal cord injury patient have spared Upper extremities and some trunk muscle with use of those and some assistive devices patient can achieve the independence in his life

      Commentry Pages: 1 - 2

      Vitamin B12 deficiency anemia is pernicious anemia

      Bunkechukwu Mehemed

      Frailty with bone marrow promegaloblastosis (megaloblastic weakness). This is because of the restraint of DNA blend (explicitly purines and thymidine). Gastrointestinal side effects: modification in inside motility, like gentle the runs or blockage, and loss of bladder or gut control. These are believed to be because of flawed DNA amalgamation repressing replication in tissue destinations with a high turnover of cells. This may likewise be because of the immune system assault on the parietal cells of the stomach in noxious paleness. There is a relationship with gastric antral vascular ectasia (which can be alluded to as watermelon stomach), and malicious anemia. Neurological manifestations: tangible or engine insufficiencies (missing reflexes, lessened vibration or delicate touch sensation) and sub acute consolidated degeneration of the spinal cord. Deficiency side effects in kids incorporate formative postponement, relapse, peevishness, compulsory developments and hypotonia.

          Commentary Pages: 1 - 2

          Piezo1 Places a Brake on Megakaryocyte Maturation and Platelet Biogenesis

          Katya Ravid* and Alessandra Balduini

          Years after the discovery of Piezo1/2 cation channels by Ardem Patapoutian and colleagues [1], investigations have continued, unfolding intriguing properties of these channels, the name of which means squeeze/press in Greek. Piezo1 and Piezo 2 are expressed in various cell types, with varying responses to mechanical forces projected by the extracellular matrix. The role of Piezo1 protein in maintenance of red blood cells shape and function has been reported in context of human mutations affecting this channel. A recent paper by Abbonante, et al. [2] described new roles for Piezo1 in affecting the development of a relatively rare hematopoietic cell, the Megakaryocyte (MK), as well as the level of its progeny, blood platelets, in health and disease.

          Commentry Pages: 1 - 2

          Pomalidomide treatment enhances survival in myeloma patients via immune modulation

          Rao Prabhala*, Hannah Seah, Vaishnavi Bade, Srikanth Talluri

          Pomalidomide is an immune-modulatory drug, structurally related to thalidomide and lenalidomide. It is approved by the Food and Drug Administration (FDA) for the treatment of Multiple Myeloma (MM). These three immunemodulatory drugs are known to target cereblon, an E3 ubiquitin, and to increase the degradation of Ikaros family of Zinc Finger protein 1 and 3 (IKZF1/3) transcription factors. Downstream related-proteins, including Interferon Regulatory Factor-4 (IRF-4) and c-Myc are also downregulated by these immunemodulatory drugs. Their anti-tumor effects are directly cytotoxic to MM cells and may in part improve antimyeloma responses of Natural Killer (NK) and T-cells. The clinical responses and survival benefits of these immune- modulatory drugs might be due to their ability to blockade certain check-point inhibitory molecules on immune cells. In a randomized, open-label, international phase 3 trial with 559 relapsed/refractory MM patients were treated with Pomalidomide, Velcade, and Dexamethasone (PVd) or Velcade, and Dexamethasone (Vd).

          Brief Report Pages: 1 - 2

          The Therapeutic Potential of X-Irradiated Umbilical Cord Blood Cells in Neuroregeneration and Tissue Repair Mechanism

          Kazuta Yasui, Akihiro Fuchizaki, Yoshihiro Takihara and Takafumi Kimura*

          Since regenerative therapy with stem cells is believed to exert an effect based on their proliferation and differentiation potential, anything that would cause the loss of these capacities, such as irradiation, may negate the anticipated effect. In this study, X-irradiated (XR) mononuclear cells were prepared from umbilical cord blood. Even though hematopoietic stem/progenitor cell activity was diminished in the XR cells, the regenerative activity was surprisingly conserved and aided recovery from experimental stroke in mice. Here, we provide evidence indicating the possible therapeutic mechanisms by which damaged cerebrovascular endothelial cells may be rescued by low-molecular-weight metabolites supplied by injected XR cells via gap junctions as energy sources to improve blood flow in the infarcted area. Thus, XR cells may exhibit tissue repair capabilities through the activation of endothelial cells, rather than via cell-autonomous effects.

Google Scholar citation report
Citations: 443

Journal of Blood & Lymph received 443 citations as per Google Scholar report

Journal of Blood & Lymph peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward